Novavax
NVAX
#5518
Rank
S$1.88 B
Marketcap
S$11.49
Share price
3.74%
Change (1 day)
42.91%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of March 2026 : S$0.38 Billion

According to Novavax's latest financial reports the company's total debt is S$0.38 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$0.31 B1.99%
2024-12-31S$0.31 B3.52%
2023-12-31S$0.30 B-58.95%
2022-12-31S$0.73 B20.09%
2021-12-31S$0.61 B-0.86%
2020-12-31S$0.61 B42.67%
2019-12-31S$0.43 B-0.48%
2018-12-31S$0.43 B2.6%
2017-12-31S$0.42 B-7.17%
2016-12-31S$0.45 B81841.15%
2015-12-31S$0.55 M-57.63%
2014-12-31S$1.31 M-44.67%
2013-12-31S$2.38 M61.73%
2012-12-31S$1.47 M255.58%
2011-12-31S$0.41 M-19.57%
2010-12-31S$0.51 M-24.48%
2009-12-31S$0.68 M-97.92%
2008-12-31S$32.76 M0.08%
2007-12-31S$32.73 M-7.94%
2006-12-31S$35.55 M-30.05%
2005-12-31S$50.83 M-16.16%
2004-12-31S$60.62 M-15.37%
2003-12-31S$71.63 M-0.28%
2002-12-31S$71.84 M13.02%
2001-12-31S$63.56 M83.38%
2000-12-31S$34.66 M20718.62%
1999-12-31S$0.16 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
S$60.79 B 15,828.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$82.43 B 21,499.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$43.87 B 11,395.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$32.64 B 8,453.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$1.34 B 251.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$2.46 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$59.2 M-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$1.94 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.05 B 177.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.85 B 124.74%๐Ÿ‡บ๐Ÿ‡ธ USA